MELBOURNE, Australia, Nov. 4, 2015/Medianet International-AsiaNet/ --
Gordagen
Pharmaceuticals, a privately held Australian company commercializing
tocotrienol-based nutraceuticals and pharmaceuticals, has appointed
Nutritional Products International, Inc. (NPI) as its exclusive US
marketing and distribution partner for its Heart Health nutraceutical
product.
nE1-Heart(TM) is an evidence-based nutraceutical for the
maintenance of a healthy heart and is planned for release in the US
during the first half of 2016, bringing forward previously forecasted
revenues for the company. The US represents one of the largest
nutraceutical markets in the world.
http://mrem.bernama.com/viewsm.php?idm=25650
No comments:
Post a Comment